Ana Luiza Pamplona Mosimann
Oswaldo Cruz Foundation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ana Luiza Pamplona Mosimann.
Memorias Do Instituto Oswaldo Cruz | 2015
Camila Zanluca; Vanessa Campos Andrade de Melo; Ana Luiza Pamplona Mosimann; Glauco Igor Viana dos Santos; Claudia Nunes Duarte dos Santos; Kleber Giovanni Luz
In the early 2015, several cases of patients presenting symptoms of mild fever, rash, conjunctivitis and arthralgia were reported in the northeastern Brazil. Although all patients lived in a dengue endemic area, molecular and serological diagnosis for dengue resulted negative. Chikungunya virus infection was also discarded. Subsequently, Zika virus (ZIKV) was detected by reverse transcription-polymerase chain reaction from the sera of eight patients and the result was confirmed by DNA sequencing. Phylogenetic analysis suggests that the ZIKV identified belongs to the Asian clade. This is the first report of ZIKV infection in Brazil.
Journal of Virology | 2011
Guilherme Ferreira Silveira; Florencia Meyer; Adriana Delfraro; Ana Luiza Pamplona Mosimann; Norma Coluchi; Cyntia Vasquez; Christian Macagnan Probst; André Báfica; Juliano Bordignon; Claudia Nunes Duarte dos Santos
ABSTRACT A recent (2007 to 2009) dengue outbreak caused by dengue virus (DENV) in Paraguay presented unusual severe clinical outcomes associated with 50% mortality rates. Although it has been reported that inflammatory responses influence the severity of dengue virus infection (T. Pang, M. J. Cardosa, and M. G. Guzman, Immunol. Cell Biol. 85:43–45, 2007), there remains a paucity of information on virus-innate immunity interactions influencing clinical outcome. Using human dendritic cells from a major innate immune cell population as an in vitro model, we have investigated signature cytokine responses as well as infectivity-replicative profiles of DENV clinical isolates from either a nonfatal case of classical dengue fever (strain DENV3/290; isolated in Brazil in 2002) or a fatal case of dengue fever with visceral complications isolated in Paraguay in 2007 (strain DENV3/5532). Strain DENV3/5532 was found to display significantly higher replicative ability than DENV3/290 in monocyte-derived dendritic cells (mdDCs). In addition, compared to DENV3/290 results, mdDCs exposed to DENV3/5532 showed increased production of proinflammatory cytokines associated with higher rates of programmed cell death, as shown by annexin V staining. The observed phenotype was due to viral replication, and tumor necrosis factor alpha (TNF-α) appears to exert a protective effect on virus-induced mdDC apoptosis. These results suggest that the DENV3/5532 strain isolated from the fatal case replicates within human dendritic cells, modulating cell survival and synthesis of inflammatory mediators.
Virology | 2008
Juliano Bordignon; Christian Macagnan Probst; Ana Luiza Pamplona Mosimann; Daniela Parada Pavoni; Vanessa Stella; Gregory A. Buck; Nusara Satproedprai; Paul Fawcett; Silvio M. Zanata; Lúcia de Noronha; Marco A. Krieger; Claudia Nunes Duarte dos Santos
Dengue virus (DENV) infection can cause a self-limiting disease (dengue fever) or a more severe clinical presentation known as dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Furthermore, data from recent dengue epidemics in Brazil indicate that the neurological manifestations are becoming more prevalent. However, the neuropathogenesis of dengue are not well understood. The balance between viral replication efficiency and innate immunity--in opposition during the early stages of infection--determines the clinical outcome of DENV infection. In this study, we investigated the effects of DENV infection on the transcription profile of the central nervous system (CNS) of mice. We observed in infected mice the up-regulation of 151 genes possibly involved in neuropathogenesis of dengue. Conversely, they may have a protective effect. Ingenuity Systems software analysis demonstrated, that the main pathways modulated by DENV infection in the mouse CNS are involved in interferon signaling and antigen presentation.
PLOS Neglected Tropical Diseases | 2013
Deu John M. Cruz; Andrea Cristine Koishi; Juliana Bosso Taniguchi; Xiaolan Li; Rafaela Milan Bonotto; Joo Hwan No; Keum Hyun Kim; Sungmin Baek; Hee-Young Kim; Marc P. Windisch; Ana Luiza Pamplona Mosimann; Luana de Borba; Michel Liuzzi; Michael Adsetts Edberg Hansen; Claudia Nunes Duarte dos Santos; Lucio H. Freitas-Junior
Dengue virus is a mosquito-borne flavivirus that has a large impact in global health. It is considered as one of the medically important arboviruses, and developing a preventive or therapeutic solution remains a top priority in the medical and scientific community. Drug discovery programs for potential dengue antivirals have increased dramatically over the last decade, largely in part to the introduction of high-throughput assays. In this study, we have developed an image-based dengue high-throughput/high-content assay (HT/HCA) using an innovative computer vision approach to screen a kinase-focused library for anti-dengue compounds. Using this dengue HT/HCA, we identified a group of compounds with a 4-(1-aminoethyl)-N-methylthiazol-2-amine as a common core structure that inhibits dengue viral infection in a human liver-derived cell line (Huh-7.5 cells). Compounds CND1201, CND1203 and CND1243 exhibited strong antiviral activities against all four dengue serotypes. Plaque reduction and time-of-addition assays suggests that these compounds interfere with the late stage of viral infection cycle. These findings demonstrate that our image-based dengue HT/HCA is a reliable tool that can be used to screen various chemical libraries for potential dengue antiviral candidates.
Antiviral Research | 2014
Yong-Jun Kwon; Jinyeong Heo; Hazel E.E. Wong; Deu John M. Cruz; Sumathy Velumani; Camila T. da Silva; Ana Luiza Pamplona Mosimann; Claudia Nunes Duarte dos Santos; Lucio H. Freitas-Junior; Katja Fink
Dengue is a global emerging infectious disease, with no specific treatment available. To identify novel human host cell targets important for dengue virus infection and replication, an image-based high-throughput siRNA assay screening of a human kinome siRNA library was conducted using human hepatocyte cell line Huh7 infected with a recent dengue serotype 2 virus isolate BR DEN2 01-01. In the primary siRNA screening of 779 kinase-related genes, knockdown of 22 genes showed a reduction in DENV-2 infection. Conversely, knockdown of 8 genes enhanced viral infection. To assess host cell specificity, the confirmed hits were tested in the DENV-infected monocytic cell line U937. While the expression of EIF2AK3, ETNK2 and SMAD7 was regulated in both cell lines after infection, most kinases were hepatocyte-specific. Monocytic cells represent initial targets of infection and an antiviral treatment targeting these cells is probably most effective to reduce initial viral load. In turn, infection of the liver could contribute to pathogenesis, and the novel hepatocyte-specific human targets identified here could be important for dengue infection and pathogenesis.
Memorias Do Instituto Oswaldo Cruz | 2011
Ana Luiza Pamplona Mosimann; Juliano Bordignon; Giovanny Augusto Camacho Antevere Mazzarotto; Maria Cristina M. Motta; Federico G. Hoffmann; Claudia Nunes Duarte dos Santos
Brevidensoviruses have an encapsidated, single-stranded DNA genome that predominantly has a negative polarity. In recent years, they have received particular attention due to their potential role in the biological control of pathogenic arboviruses and to their unnoticed presence in cell cultures as contaminants. In addition, brevidensoviruses may also be useful as viral vectors. This study describes the first genetic and biological characterization of a mosquito densovirus that was isolated in Brazil; moreover, we examined the phylogenetic relationship between this isolate and the other brevidensoviruses. We further demonstrate that this densovirus has the potential to be used to biologically control dengue virus (DENV) infection with in vitro co-infection experiments. The present study provides evidence that this densovirus isolate is a fast-spreading virus that affects cell growth and DENV infection.
Acta Tropica | 2017
Taissa Ricciardi Jorge; Ana Luiza Pamplona Mosimann; Lúcia de Noronha; Angela Maron; Claudia Nunes Duarte dos Santos
During a series of epizootics caused by Yellow fever virus in Brazil between 2007 and 2009, a monkey was found dead (May 2009) in a sylvatic area in the State of Paraná. Brain samples from this animal were used for immunohistochemical analysis and isolation of a wild-type strain of YFV. This viral strain was characterized, and sequence analyzes demonstrated that it is closely related with YFV strains of the recently identified subclade 1E of the South American genotype I. Further characterization included indirect-immunofluorescence of different infected cell lines and analysis of the kinetics of virus replication and infectivity inhibition by type I IFN. The generated data contributes to the knowledge of YFV evolution and phylogeny. Additionally, the reagents generated and characterized during this study, such as a panel of monoclonal antibodies, are useful tools for further studies on YFV. Lastly, this case stresses the importance of yellow fever surveillance through sentinel monkeys.
Scientific Reports | 2017
Taissa Ricciardi-Jorge; Juliano Bordignon; Andrea Cristine Koishi; Camila Zanluca; Ana Luiza Pamplona Mosimann; Claudia Nunes Duarte dos Santos
Yellow fever is an arboviral disease that causes thousands of deaths every year in Africa and the Americas. However, few commercial diagnostic kits are available. Non-structural protein 1 (NS1) is an early marker of several flavivirus infections and is widely used to diagnose dengue virus (DENV) infection. Nonetheless, little is known about the dynamics of Yellow fever virus (YFV) NS1 expression and secretion, to encourage its use in diagnosis. To tackle this issue, we developed a quantitative NS1-capture ELISA specific for YFV using a monoclonal antibody and recombinant NS1 protein. This test was used to quantify NS1 in mosquito and human cell line cultures infected with vaccine and wild YFV strains. Our results showed that NS1 was detectable in the culture supernatants of both cell lines; however, a higher concentration was maintained as cell-associated rather than secreted into the extracellular milieu. A panel of 73 human samples was used to demonstrate the suitability of YFV NS1 as a diagnostic tool, resulting in 80% sensitivity, 100% specificity, a 100% positive predictive value and a 95.5% negative predictive value compared with RT-PCR. Overall, the developed NS1-capture ELISA showed potential as a promising assay for the detection of early YF infection.
Virus Evolution | 2018
Ana Luiza Pamplona Mosimann; Taissa Ricciardi Jorge; Lúcia de Noronha; Angela Maron; C. N. Duarte dos Santos
cervical samples from a cohort of young women attending cervical screening with access to HPV vaccination in Luxembourg. DNA extracts of eighty-one cervical swabs from women (mean age 23 years) positive for HPV by AnyplexIIHPV28 VR (Seegene) were enriched by rolling circle amplification and sequenced on Illumina Miseq. Reads were mapped to 182 PaVE reference sequences of known HPV types using BBMap and assembled using VELVET. Complete HPV genomes obtained were aligned with genomes published in Genbank using MEGA6. Overall, an average of 1 per cent of reads mapped to HPV. Among the eightyone positive samples, NGS-RCA detected 186 different HPV types spanning thirty-six of the fifty-one known mucosal types. HPV types 42, 53, 51, 56, 90, and 31 were most frequently detected in twenty-two, fifteen, ten, ten, nine, and seven samples, respectively. Detection of HPV types by NGS-RCA was highly correlated with viral load of Anyplex. About sixty-seven consensus sequences of complete HPV genomes were assembled including two novel lineages of HPV66 and HPV90 and two novel sublineage of HPV67 and HPV73, respectively. NGS-RCA is a powerful method for obtaining complete HPV genomes from cervical samples with a high viral load (Ct< 30). After eight years of the vaccination programme in Luxembourg, vaccinerelated types 6, 11, 16, and 18 were infrequently detected in the targeted age group.
Parasites & Vectors | 2018
Ana Luiza Pamplona Mosimann; Mirian Krystel de Siqueira; Ligia Fernanda Ceole; Claudia Nunes Duarte dos Santos
BackgroundA new isolate of Aura virus serendipitously discovered as a cell culture contaminant is reported in this manuscript. Aura virus belongs to the family Togaviridae and is classified in the genus Alphavirus. There are only two reports of Aura virus isolation from mosquitoes in the scientific literature, and the existence of a vertebrate host is still unknown. The discovery of this new isolate was based on transmission electron microscopy and nucleic acid amplification through a non-specific RT-PCR amplification protocol followed by sequencing.ResultsGenetic analysis has shown that the new virus shares a high degree of identity with the previously described isolate (GenBank: AF126284.1). A major difference was observed in the nsP3 gene in which a 234-nucleotide duplication has been identified. Furthermore, a pronounced difference was observed in cell cultures compared to the data available for the previously described isolate. Cell permissiveness and phenotypic characteristics in C6/36, Vero and BHK-21 cells were found to differ from previous reports. This may be due to the genetic differences that have been observed.ConclusionsThe genetic and biological characteristics of the new Aura virus isolate are suggestive of viral adaptation to the cell substrate. The development of a cDNA clone will lend a perspective and better understanding of these results as well as open avenues for its use as a biotechnological tool, as seen for other alphaviruses.